Evaluation of serum antibody responses of Madras red sheep to excretory / secretory antigen of Haemonchus contortus

2011 ◽  
Vol 5 (6) ◽  
pp. 523
Author(s):  
ARUNKUMAR SELVARAYAR ◽  
ABDUL AMEED
Keyword(s):  
Haemonchus Contortus ◽  
Serum Antibody ◽  
Antibody Responses ◽  
Secretory Antigen ◽  
Excretory Secretory Antigen

Serum antibody responses of Texel sheep experimentally infected with Haemonchus contortus

1994 ◽  
Vol 57 (1) ◽  
pp. 63-68 ◽  
Author(s):  
H.D.F.H. Schallig ◽  
M.A.W. Van Leeuwen ◽  
W.E. Bernadina ◽  
W.M.L. Hendrikx
Keyword(s):  
Haemonchus Contortus ◽  
Serum Antibody ◽  
Antibody Responses

Identification of a 66kDa Haemonchus contortus excretory/secretory antigen that inhibits host monocytes

2006 ◽  
Vol 138 (3-4) ◽  
pp. 291-300 ◽  
Author(s):  
D.K. Rathore ◽  
S. Suchitra ◽  
M. Saini ◽  
B.P. Singh ◽  
P. Joshi
Keyword(s):  
Haemonchus Contortus ◽  
Secretory Antigen ◽  
Excretory Secretory Antigen

scholarly journals Serum antibody responses in Creole kids experimentally infected with Haemonchus contortus

2008 ◽  
Vol 158 (4) ◽  
pp. 311-318 ◽  
Author(s):  
Jean-Christophe Bambou ◽  
Claudia de la Chevrotière ◽  
Hugues Varo ◽  
Remy Arquet ◽  
Frans N.J. Kooyman ◽  
...  
Keyword(s):  
Haemonchus Contortus ◽  
Serum Antibody ◽  
Antibody Responses

Isotype-specific serum antibody responses of sheep to Haemonchus contortus antigens

1995 ◽  
Vol 56 (1-3) ◽  
pp. 149-162 ◽  
Author(s):  
Henk D.F.H. Schallig ◽  
Marianne A.W. van Leeuwen ◽  
Wim M.L. Hendrikx
Keyword(s):  
Haemonchus Contortus ◽  
Serum Antibody ◽  
Antibody Responses ◽  
Specific Serum

The excretory-secretory antigen HcADRM1 to generate protective immunity against Haemonchus contortus

Parasitology ◽  
2021 ◽  
pp. 1-39
Author(s):  
Mingmin Lu ◽  
Xiaowei Tian ◽  
Wenjuan Wang ◽  
Yang Zhang ◽  
Kalibixiati Aimulajiang ◽  
...  
Keyword(s):  
Haemonchus Contortus ◽  
Protective Immunity ◽  
Secretory Antigen ◽  
Excretory Secretory Antigen

scholarly journals Low Immunogenicity of Intravesical Phage Therapy for Urogenitary Tract Infections

Antibiotics ◽  
2021 ◽  
Vol 10 (6) ◽  
pp. 627
Author(s):  
Sławomir Letkiewicz ◽  
Marzanna Łusiak-Szelachowska ◽  
Ryszard Międzybrodzki ◽  
Maciej Żaczek ◽  
Beata Weber-Dąbrowska ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Bacterial Infections ◽  
Phage Therapy ◽  
Serum Antibody ◽  
Multidrug Resistant ◽  
Antibody Responses ◽  
Urogenital Infections ◽  
Reliable Model ◽  
Tract Infections ◽  
Antibody Levels

Patients with chronic urinary and urogenital multidrug resistant bacterial infections received phage therapy (PT) using intravesical or intravesical and intravaginal phage administration. A single course of PT did not induce significant serum antibody responses against administered phage. Whilst the second cycle of PT caused a significant increase in antibody levels, they nevertheless remained quite low. These data combined with good therapy results achieved in some patients suggest that this mode of PT may be an efficient means of therapy for urogenital infections and a reliable model for a clinical trial of PT.

scholarly journals Induction of Mucosal Protection against Primary, Heterologous Simian Immunodeficiency Virus by a DNA Vaccine

2002 ◽  
Vol 76 (7) ◽  
pp. 3309-3317 ◽  
Author(s):  
Deborah Heydenburg Fuller ◽  
Premeela A. Rajakumar ◽  
Lawrence A. Wilson ◽  
Anita M. Trichel ◽  
James T. Fuller ◽  
...  
Keyword(s):  
Simian Immunodeficiency Virus ◽  
Dna Vaccine ◽  
Dna Sequences ◽  
Serum Antibody ◽  
Antibody Responses ◽  
Effective Vaccine ◽  
Lymphoid Tissues ◽  
Mucosal Protection ◽  
Mucosal Transmission ◽  
Immunodeficiency Virus

ABSTRACT An effective vaccine against human immunodeficiency virus (HIV) should protect against mucosal transmission of genetically divergent isolates. As a safe alternative to live attenuated vaccines, the immunogenicity and protective efficacy of a DNA vaccine containing simian immunodeficiency virus (SIV) strain 17E-Fr (SIV/17E-Fr) gag-pol-env was analyzed in rhesus macaques. Significant levels of cytotoxic T lymphocytes (CTL), but low to undetectable serum antibody responses, were observed following multiple immunizations. SIV-specific mucosal antibodies and CTL were also detected in rectal washes and gut-associated lymphoid tissues, respectively. Vaccinated and naive control monkeys were challenged intrarectally with SIV strain DeltaB670 (SIV/DeltaB670), a primary isolate whose env is 15% dissimilar to that of the vaccine strain. Four of seven vaccinees were protected from infection as determined by the inability to identify viral RNA or DNA sequences in the peripheral blood and the absence of anamnestic antibody responses postchallenge. This is the first report of mucosal protection against a primary pathogenic, heterologous isolate of SIV by using a commercially viable vaccine approach. These results support further development of a DNA vaccine for protection against HIV.

Sign in / Sign up

Export Citation Format

Share Document